XLO NASDAQ
Xilio Therapeutics, Inc.
1W: -0.3%
1M: +1.9%
3M: -4.6%
YTD: +1241.4%
1Y: +982.1%
3Y: +327.0%
$9.01
+0.10 (+1.12%)
Weekly Expected Move ±2.0%
$9
$9
$9
$9
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-03-28
Earliest Filing
2025-03-11
Latest Filing
partner: 3
investor: 1
Counterparties (Filed by XLO)
4 relationshipsCompanies named in XLO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Leerink Partners LLC | — | partner | Sales agent for the Company's at-the-market offering of common stock | 2025-03-11 | View |
| AbbVie Group Holdings Limited | ABBV | partner | Entered into a collaboration, license and option agreement for tumor-activation technology programs | 2025-02-12 | View |
| AbbVie Inc. | ABBV | investor | Purchased common stock in a private placement and entered into an investor rights agreement | 2025-02-12 | View |
| Gilead Sciences, Inc. | GILD | partner | Exclusive global license agreement for XTX301 and equity investment | 2024-03-28 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-12 | Earnings Release; Exhibits | View | |
| 2026-06-12 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-04-16 | Officer/Director Change; Exhibits | View | |
| 2026-03-23 | Earnings Release; Exhibits | View | |
| 2026-03-12 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2026-03-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-24 | Submission of Matters to a Vote of Security Holders | View | |
| 2026-02-12 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2026-01-08 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2026-01-05 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-25 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-11-13 | Results of Operations and Financial Condition | View | |
| 2025-11-07 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-10-03 | Notice of Delisting or Transfer | View | |
| 2025-09-09 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-28 | Notice of Delisting or Transfer | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-10 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR